Mercado terapéutico del virus de la inmunodeficiencia humana (VIH)-1: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00016876
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

LANZAMIENTO AL MERCADO Las terapias contra el virus de la inmunodeficiencia humana (VIH)-1 son medicamentos que se utilizan para tratar el VIH. El VIH es una infección viral que afecta las células del cuerpo que ayudan a combatir las infecciones y hacen que el cuerpo sea más susceptible a otras infecciones oportunistas. Se encuentran disponibles varias clases de terapias farmacológicas para tratar el virus de la inmunodeficiencia humana. DINÁMICA DEL MERCADO Los impulsores del mercado más importantes para el mercado de terapias contra el virus de la inmunodeficiencia humana (VIH)-1 incluyen extensas actividades de investigación y desarrollo por parte de compañías farmacéuticas para desarrollar terapias novedosas, aumentando las tasas de transmisión de infecciones en todo el mundo y La falta de conciencia sobre las infecciones por VIH en los países en desarrollo son algunos de los factores que se espera que impulsen el crecimiento del mercado durante el período previsto. Los altos costos de tratamiento y las estrictas aprobaciones regulatorias para terapias con medicamentos podrían frenar el crecimiento del mercado durante el período previsto. s ALCANCE DEL MERCADO El “Mercado Terapéutico del Virus de Inmunodeficiencia Humana (VIH)-1” es un estudio especializado y en profundidad de la industria farmacéutica con un enfoque particular en el análisis de tendencias del mercado global. El informe tiene como objetivo proporcionar una descripción general del mercado terapéutico del virus de la inmunodeficiencia humana (VIH)-1 con una segmentación detallada del mercado por clase de medicamento y aplicación. Se espera que el mercado terapéutico del virus de la inmunodeficiencia humana (VIH)-1 experimente un alto crecimiento durante el período de pronóstico. El informe proporciona estadísticas clave sobre el estado del mercado de los principales actores en el mercado de terapias contra el virus de la inmunodeficiencia humana (VIH)-1 y proporciona tendencias y oportunidades clave en el mercado. SEGMENTACIÓN DEL MERCADO El mercado de terapias contra el virus de la inmunodeficiencia humana (VIH)-1 está segmentado por clase de fármaco y aplicación. Según la clase de fármaco, el mercado se segmenta en NRTIS, NNRTIS, inhibidores de entrada y fusión, inhibidores de proteasa e inhibidores de integrasa. Y según la aplicación, el mercado se segmenta en hospitales, clínicas y otros.

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market: Strategic Insights

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Gilead Sciences Inc
  • ViiV Healthcare
  • AbbVie Inc
  • Merck and Co Inc
  • Bristol Myers Squibb Company
  • Boehringer Ingelheim GmbH
  • Genentech Inc
  • Cipla Inc
  • janssen Pharmaceutica

Regional Overview

Regional And Country Scope
  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central
  • Medio Oriente y África

Market Segmentation

Segment 1Clase de fármaco
  • inhibidores de la transcriptasa inversa análogos de nucleósidos
Segment2Aplicación
  • Hospital
  • Clínicas
  • Otros
Segment3Geografía
  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central
El informe proporciona una descripción detallada de la industria, incluyendo información cualitativa y cuantitativa. Proporciona una descripción general y un pronóstico del mercado terapéutico del virus de la inmunodeficiencia humana (VIH)-1 en función de varios segmentos. También proporciona el tamaño del mercado y estimaciones de pronóstico para los años 2021 a 2031 con respecto a cinco regiones principales, a saber: América del Norte, Europa, Asia Pacífico (APAC), Medio Oriente y África (MEA) y América del Sur y Central. El mercado terapéutico del virus de la inmunodeficiencia humana (VIH)-1 por región se divide posteriormente en los respectivos países y segmentos. El informe incluye análisis y pronósticos para 18 países de todo el mundo, así como tendencias y oportunidades actuales en la región. El informe analiza los factores que afectan el mercado terapéutico del virus de la inmunodeficiencia humana (VIH)-1 tanto desde el lado de la demanda como de la oferta y evalúa en mayor profundidad la dinámica del mercado que afecta al mercado durante el período de pronóstico, es decir, impulsores, restricciones, oportunidades y tendencias futuras. El informe también proporciona un análisis integral de plagas para las cinco regiones, a saber: América del Norte, Europa, APAC, MEA y América del Sur y Central después de evaluar los factores políticos, económicos, sociales y tecnológicos que afectan el mercado terapéutico del virus de la inmunodeficiencia humana (VIH) -1 en estas regiones. ACTORES DEL MERCADO El informe cubre desarrollos clave en las estrategias de crecimiento orgánico e inorgánico del mercado de terapias para el virus de la inmunodeficiencia humana (VIH)-1. Varias empresas se centran en estrategias de crecimiento orgánico como lanzamientos de productos, aprobaciones de productos y otros como patentes y eventos. Las estrategias de crecimiento inorgánico observadas en el mercado incluyeron adquisiciones, asociaciones y colaboraciones. Estas actividades han allanado el camino para la expansión de la base de negocios y clientes de los participantes del mercado. Se espera que los actores del mercado de terapias contra el virus de la inmunodeficiencia humana (VIH)-1 tengan oportunidades de crecimiento lucrativas en el futuro a medida que la demanda de terapias contra el virus de la inmunodeficiencia humana (VIH)-1 esté aumentando en el mercado global. A continuación se muestra una lista de algunas de las empresas que operan en el mercado terapéutico del virus de la inmunodeficiencia humana (VIH)-1. El informe también incluye los perfiles de actores clave en el mercado de terapias contra el virus de la inmunodeficiencia humana (VIH)-1 junto con su análisis FODA y estrategias de mercado. Además, el informe se centra en los principales actores de la industria con información como perfiles de empresas, componentes y servicios ofrecidos, información financiera de los últimos tres años y desarrollos clave en los últimos cinco años.
    •  Gilead Sciences, Inc. •  Merck and Co, Inc •  Viiv Atención sanitaria •  AbbVie, Inc. •  Compañía Bristol-Myers Squibb •  Boehringer Ingelheim GmbH •  Genentech, Inc. •  Cipla, Inc •  Janssen Pharmaceutica •  El equipo dedicado de investigación y análisis de Johnson and Johnson
Insight Partner está formado por profesionales experimentados con conocimientos estadísticos avanzados y ofrece varias opciones de personalización en el estudio existente.

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Clase de fármaco
  • inhibidores de la transcriptasa inversa análogos de nucleósidos
By Aplicación
  • Hospital
  • Clínicas
  • Otros
By Geografía
  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central
Regions and Countries Covered América del Norte
  • EE. UU.
  • Canadá
  • México
Europa
  • Reino Unido
  • Alemania
  • Francia
  • Rusia
  • Italia
  • resto de Europa
Asia-Pacífico
  • China
  • India
  • Japón
  • Australia
  • resto de Asia-Pacífico
América del Sur y Central
  • Brasil
  • Argentina
  • Resto de América del Sur y Central
Medio Oriente y África
  • Sudáfrica
  • Arabia Saudita
  • Emiratos Árabes Unidos
  • Resto de Medio Oriente y África
Market leaders and key company profiles
  • Gilead Sciences Inc
  • ViiV Healthcare
  • AbbVie Inc
  • Merck and Co Inc
  • Bristol Myers Squibb Company
  • Boehringer Ingelheim GmbH
  • Genentech Inc
  • Cipla Inc
  • janssen Pharmaceutica
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Gilead Sciences, Inc
    2. ViiV Healthcare
    3. AbbVie, Inc
    4. Merck and Co., Inc
    5. Bristol-Myers Squibb Company
    6. Boehringer Ingelheim GmbH
    7. Genentech, Inc
    8. Cipla,Inc
    9. janssen Pharmaceutica
    10. Johnson and Johnson

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..